organophosphonates has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lampertico, P; Mangia, G; Viganò, M | 1 |
| Adamidi, S; Alexopoulou, A; Deutsch, M; Koskinas, JS; Manolakopoulos, S; Pectasides, D; Skondra, M; Tampaki, M | 1 |
| Andrei, G; De Clercq, E; Holý, A; Krecmerová, M; Naesens, L; Neyts, J; Snoeck, R; Votruba, I | 1 |
| Holý, A; Otová, B; Votruba, I | 1 |
| Belvisi, V; Cenfra, N; Cimino, G; Del Borgo, C; Lichtner, M; Marocco, R; Mastroianni, CM; Mecarocci, S; Rago, A | 1 |
| Enomoto, M; Hino, M; Nishiguchi, S; Seki, S; Yamane, T | 1 |
| Barozzi, P; Cavanna, L; Longo, G; Luppi, M; Morselli, M; Potenza, L; Ravazzini, L; Re, A; Riva, G; Roncaglia, R; Rossi, G; Torelli, G; Trovato, R; Vallisa, D | 1 |
| Kulick, KB; Osswald, SS; Sperling, LC; Tomaszewski, MM | 1 |
| Castelló Miralles, I; Del Val Antoñana, A; Moreno-Osset, E; Muñoz Vicente, M | 1 |
| Allen, SL; Costanza, M; Henderson, IC; Ratain, MJ; Rosner, G; Schilsky, RL; Van Echo, DA | 1 |
| Bordigoni, P; Carret, AS; Corsaro, D; Dauendorffer, JN; Edert, D; Le Faou, A; Venard, V | 1 |
2 review(s) available for organophosphonates and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.
Topics: Adenine; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Carrier State; Disease Management; DNA, Viral; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Organophosphonates; Rituximab; Tenofovir; Virus Activation | 2014 |
[Acyclic nucleoside phosphonates as potential antineoplastic agents].
Topics: Adenine; Alanine; Animals; Antineoplastic Agents; Cell Line, Tumor; Guanine; Humans; Lymphoma, Non-Hodgkin; Nucleosides; Organophosphonates; Organophosphorus Compounds; Purines | 2008 |
1 trial(s) available for organophosphonates and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
Population pharmacodynamic study of amonafide: a Cancer and Leukemia Group B study.
Topics: Acetylation; Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Imides; Isoquinolines; Leukopenia; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Middle Aged; Multivariate Analysis; Naphthalimides; Organophosphonates; Racial Groups; Regression Analysis; Serum Albumin; United States | 1995 |
8 other study(ies) available for organophosphonates and Diffuse Mixed Small and Large Cell Lymphoma
| Article | Year |
|---|---|
The role of tenofovir in preventing and treating hepatitis B virus (HBV) reactivation in immunosuppressed patients. A real life experience from a tertiary center.
Topics: Adenine; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Female; Hepatitis B; Humans; Immunocompromised Host; Immunologic Factors; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Organophosphonates; Rituximab; Tenofovir; Virus Activation | 2014 |
Intracellular metabolism of the new antiviral compound 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Cidofovir; Cytosine; DNA Replication; DNA Viruses; DNA, Neoplasm; Drug Stability; Female; Herpesvirus 1, Human; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred Strains; Organophosphonates | 2008 |
Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen.
Topics: Adenine; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Drug Combinations; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Organophosphonates; Rituximab; Tenofovir; Virus Activation | 2010 |
Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
Topics: Adenine; Adult; Antiviral Agents; Carrier State; Drug Resistance; Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Organophosphonates; Reverse Transcriptase Inhibitors | 2004 |
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cidofovir; Cytosine; Herpesvirus 8, Human; Humans; Injections, Intralesional; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Organophosphonates; Remission Induction; Time Factors | 2005 |
Viral-associated trichodysplasia in a patient with lymphoma: a case report and review.
Topics: Administration, Topical; Aged; Alopecia; Antiviral Agents; Cidofovir; Cytosine; Facial Dermatoses; Hair Diseases; Hair Follicle; Humans; Inclusion Bodies, Viral; Intranuclear Inclusion Bodies; Lymphoma, Non-Hodgkin; Male; Organophosphonates; Polyomavirus; Treatment Outcome | 2007 |
[Adefovir in reactivation of chemotherapy-induced hepatitis B in an anti-Hbc-positive patient].
Topics: Adenine; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; Dacarbazine; Doxorubicin; Fatal Outcome; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lymphoma, Non-Hodgkin; Organophosphonates; Prion Diseases; Vinblastine; Virus Activation | 2007 |
Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Acute Disease; Acyclovir; Adolescent; Amino Acid Substitution; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Codon; Cytosine; DNA Mutational Analysis; Drug Resistance, Viral; Female; Foscarnet; Graft vs Host Disease; Herpes Simplex; Humans; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Point Mutation; Salvage Therapy; Simplexvirus; Thymidine Kinase; Transplantation, Homologous; Valacyclovir; Valine; Viral Proteins; Virus Activation | 2001 |